Abstract
Signal bias and membrane trafficking have recently emerged as important considerations in the therapeutic targeting of the glucagon-like peptide-1 receptor (GLP-1R) in type 2 diabetes and obesity. In the present study, we have evaluated a peptide series with varying sequence homology between native GLP-1 and exendin-4, the archetypal ligands on which approved GLP-1R agonists are based. We find notable differences in agonist-mediated cyclic AMP signaling, recruitment of β-arrestins, endocytosis, and recycling, dependent both on the introduction of a His → Phe switch at position 1 and the specific midpeptide helical regions and C-termini of the two agonists. These observations were linked to insulin secretion in a beta cell model and provide insights into how ligand factors influence GLP-1R function at the cellular level.
Original language | English |
---|---|
Pages (from-to) | 345–360 |
Number of pages | 16 |
Journal | ACS Pharmacology & Translational Science |
Volume | 3 |
Issue number | 2 |
Early online date | 17 Mar 2020 |
DOIs | |
Publication status | Published - 10 Apr 2020 |
Keywords
- GLP-1R
- biased signaling
- endocytosis
- exendin-4
- membrane trafficking
- recycling